Working… Menu

REGN5093 in Patients With MET-Altered Advanced Non-Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04077099
Recruitment Status : Recruiting
First Posted : September 4, 2019
Last Update Posted : October 29, 2021
Information provided by (Responsible Party):
Regeneron Pharmaceuticals

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 20, 2024
Estimated Study Completion Date : October 20, 2024